CiceroDx, Inc.

Release Summary

BCL6 Biomarker Predicts IVF Success and Failure in Pivotal Study. CiceroDx, exclusive provider of ReceptivaDx (BCL6 test) for unexplained Infertility

CiceroDx, Inc.